Dr. Suwicha Patnin

26 Jan 2023
0

Name : Dr. Suwicha Patnin (Research Scientist)
Office Address : Room : R312 / R303A
Laboratory of Organic Synthesis
54 Kamphaeng Phet 6 Talat Bang Khen, Lak Si, Bangkok 10210, Thailand
Tel : +66 2553 8555 (ext. 3019)
Email : [email protected]

Research Interests
Computational Drug Designing
Spectroscopy
Molecular Modeling

Education
2015 – 2020 Ph.D Applied Chemistry, Srinakharinwirot University, Thailand
2012 – 2015 M.Sc. Physical Chemistry, Srinakharinwirot University, Thailand
2008 – 2012 B.A. Chemistry, Srinakharinwirot University, Thailand

Work Experiences
2020 – present Research Scientist, Chulabhorn Research Institute, Thailand

Publications
Selected Publications

  1. Makarasen, A.; Patnin, S.; Vijitphan, P.; Reukngam, N.; Khlaychan, P.;  Techasakul, S. Structural Basis of 2-Phenylamino-4-phenoxyquinoline Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Molecules 2022, 27, 461.
  2. Patnin, S; Makarasen, A.; Kuno, M.; S. Techasakul; Vijitphan, P.; Baicharoen, A.  Computational Screening of Phenylamino-phenoxy-quinoline Derivatives against the Main Protease of SARS-COV-2 Using Molecular Docking and the ONIOM Method. Molecules 2022, 27, 1793.
  3. Vijitphan, P.; Makarasen, A.; Patnin, S.; Baicharoen, A.; Techasakul, S. In Vitro Cytotoxic Activity, Molecular Docking Study, and Chemical Composition of Zingiber cassumunar root oil. ScienceAsia 2022, 48, 596-604.
  4. Patnin, S.; Makarasen, A.; Kuno, M.; Deeyohe, S.; Techasakul, S.; Chaivisuthangkura, A. Binding Interaction of Potent HIV-1 NNRTIs, Amino-oxy-diarylquinoline with the Transport Protein Using Spectroscopic and Molecular Docking. Spectrochim. Acta-A: Mol. Biomol. Spectrosc. 2020, 233, 118159.
  5. Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-oxydiarylquinoline Derivatives as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. (Stuttg). 2019, 69, 671-682.

Tags

Share this